Louisiana Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Louisiana Health Daily.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 13, 2025

November 13, 2025

Nyxoah Reports Third Quarter 2025 Financial and Operating Results

GlobeNewswire

November 13, 2025

Nyxoah Présente ses Résultats Financiers et d’Exploitation pour le Troisième Trimestre 2025

GlobeNewswire

November 13, 2025

ORIC® Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Clinical and Operational Updates

GlobeNewswire

November 13, 2025

Fennec Pharmaceuticals Announces Proposed Offering of Common Shares

GlobeNewswire

November 13, 2025

Reviva Reports Third Quarter 2025 Financial Results and Recent Business Highlights

GlobeNewswire

November 13, 2025

Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update

GlobeNewswire

November 13, 2025

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025

GlobeNewswire

November 13, 2025

Cartesian Therapeutics Announces Strong Efficacy Signal in Phase 2 Trial of Descartes-08 in Patients with SLE and Expansion of Clinical Development into Myositis

GlobeNewswire

November 13, 2025

BioSyent Schedules Q3 and YTD 2025 Earnings Release for November 20, 2025

GlobeNewswire

November 13, 2025

BioAtla Reports Third Quarter 2025 Financial Results and Highlights Recent Progress

GlobeNewswire

November 13, 2025

Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results

GlobeNewswire

November 13, 2025

ORIC® Pharmaceuticals Announces Completion of Dose Exploration Portion of ORIC-944 Phase 1b Clinical Trial and Continues to Demonstrate Potential Best-in-Class Efficacy and Safety

GlobeNewswire

November 13, 2025

Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis

GlobeNewswire

November 13, 2025

CapsoVision Reports Third Quarter 2025 Financial Results

GlobeNewswire

November 13, 2025

Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update

GlobeNewswire

November 13, 2025

PacBio to Present at Upcoming Investor Conferences

GlobeNewswire

November 13, 2025

Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire

November 13, 2025

STRATA Skin Sciences Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

GlobeNewswire

November 13, 2025

Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights

GlobeNewswire

November 13, 2025

RenovoRx Reports Third Quarter 2025 Financial Results, Including Approximately $900,000 in Year-to-Date Revenue, and Provides Business Update

GlobeNewswire